Published in Infect Immun on June 01, 1991
Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay. Infect Immun (2000) 1.64
DNA sequences of three papA genes from uropathogenic Escherichia coli strains: evidence of structural and serological conservation. Infect Immun (1991) 1.03
Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine. Infect Immun (1993) 0.77
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Empirical predictions of protein conformation. Annu Rev Biochem (1978) 25.48
Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun (1983) 14.71
Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect Immun (1981) 14.05
Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. Proc Natl Acad Sci U S A (1981) 7.24
Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae. Infect Immun (1980) 5.19
Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun (1983) 5.10
Localization of the receptor-binding protein adhesin at the tip of the bacterial pilus. Nature (1987) 4.72
Colony hybridization. Methods Enzymol (1979) 4.47
The PapG protein is the alpha-D-galactopyranosyl-(1----4)-beta-D-galactopyranose-binding adhesin of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A (1987) 4.05
Nucleotide sequence of the papA gene encoding the Pap pilus subunit of human uropathogenic Escherichia coli. J Bacteriol (1984) 3.73
Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun (1981) 3.72
Mutations in E coli cistrons affecting adhesion to human cells do not abolish Pap pili fiber formation. EMBO J (1984) 3.18
Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest (1985) 2.97
Mannose-sensitive and mannose-resistant adherence to human uroepithelial cells and urinary virulence of Escherichia coli. Infect Immun (1980) 2.63
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Adhesion to human cells by Escherichia coli lacking the major subunit of a digalactoside-specific pilus-adhesin. Proc Natl Acad Sci U S A (1985) 2.50
Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli. N Engl J Med (1985) 2.47
The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation into the pilus. Proc Natl Acad Sci U S A (1989) 2.36
Mannose-sensitive and Gal-Gal binding Escherichia coli pili from recombinant strains. Chemical, functional, and serological properties. J Exp Med (1983) 2.27
Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet (1980) 2.23
The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition. Infect Immun (1990) 2.14
The complete amino-acid sequence of the K88 antigen, a fimbrial protein from Escherichia coli. Eur J Biochem (1981) 2.12
Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95
Distribution and degree of heterogeneity of the afimbrial-adhesin-encoding operon (afa) among uropathogenic Escherichia coli isolates. Infect Immun (1988) 1.90
Structure and antigenic properties of the tip-located P pilus proteins of uropathogenic Escherichia coli. J Bacteriol (1988) 1.64
Carbohydrate receptor structures recognized by uropathogenic E. coli. Scand J Infect Dis Suppl (1982) 1.63
Analysis of the genetic determinants coding for the S-fimbrial adhesin (sfa) in different Escherichia coli strains causing meningitis or urinary tract infections. Infect Immun (1986) 1.48
Comparison of the nucleotide sequences of the genes encoding the KS71A and F7(1) fimbrial antigens of uropathogenic Escherichia coli. Eur J Biochem (1985) 1.46
Nucleotide sequence of the gene encoding the F72 fimbrial subunit of a uropathogenic Escherichia coli strain. Gene (1984) 1.45
Distribution of the P-associated-pilus (pap) region among Escherichia coli from natural sources: evidence for horizontal gene transfer. Infect Immun (1989) 1.38
Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains. J Clin Invest (1989) 1.32
Gal-Gal pyelonephritis Escherichia coli pili linear immunogenic and antigenic epitopes. J Exp Med (1985) 1.30
Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli. J Infect Dis (1990) 1.24
Bacterial virulence in urinary tract infection. Infect Dis Clin North Am (1987) 1.23
Structure and copy number of gene clusters related to the pap P-adhesin operon of uropathogenic Escherichia coli. Infect Immun (1989) 1.09
Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model. Proc Natl Acad Sci U S A (1988) 1.08
Analysis of the primary structure of P-fimbrillins of uropathogenic Escherichia coli. Microb Pathog (1987) 1.03
Phenotypic and genotypic assays for the detection and identification of adhesins from pyelonephritic Escherichia coli. Ann Inst Pasteur Microbiol (1989) 1.01
Variable expression of P fimbriae in Escherichia coli urinary tract infection. Lancet (1989) 0.88
Characterization of Escherichia coli wild-type strains by means of agglutination with antisera raised against cloned P-, S-, and MS-fimbriae antigens, hemagglutination, serotyping and hemolysin production. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.86
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 9.92
Genetics of digalactoside-binding adhesin from a uropathogenic Escherichia coli strain. Infect Immun (1983) 4.03
Nucleotide sequence of the papA gene encoding the Pap pilus subunit of human uropathogenic Escherichia coli. J Bacteriol (1984) 3.73
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol (1990) 3.55
Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J Exp Med (1998) 3.35
Mutations in E coli cistrons affecting adhesion to human cells do not abolish Pap pili fiber formation. EMBO J (1984) 3.18
Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest (1985) 2.97
Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli. N Engl J Med (1985) 2.47
Mannose-sensitive and Gal-Gal binding Escherichia coli pili from recombinant strains. Chemical, functional, and serological properties. J Exp Med (1983) 2.27
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
NCCN Practice Guidelines for Cancer-Related Fatigue. Oncology (Williston Park) (2000) 1.88
Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J Clin Invest (1986) 1.71
Infectious disease management of adult leukemic patients undergoing chemotherapy: 1982 to 1986 experience at Stanford University Hospital. Am J Med (1989) 1.68
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer. Br J Cancer (2011) 1.65
Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc Natl Acad Sci U S A (2000) 1.50
Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I. J Immunol (2000) 1.43
Improved sensitivity of a modified polymerase chain reaction amplified DNA probe in comparison with serial tissue culture passage for detection of Chlamydia trachomatis in conjunctival specimens from nepal. Diagn Microbiol Infect Dis (1989) 1.32
Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains. J Clin Invest (1989) 1.32
Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol (1998) 1.32
Gal-Gal pyelonephritis Escherichia coli pili linear immunogenic and antigenic epitopes. J Exp Med (1985) 1.30
Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children. J Infect Dis (1993) 1.30
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol (2001) 1.22
Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood (1999) 1.20
Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Surabaya, Indonesia. Antimicrob Agents Chemother (1994) 1.18
Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides. J Immunol (2000) 1.12
Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model. Proc Natl Acad Sci U S A (1988) 1.08
DNA sequences of three papA genes from uropathogenic Escherichia coli strains: evidence of structural and serological conservation. Infect Immun (1991) 1.03
A simple, sensitive, and specific assay for the heat-stable enterotoxin of Escherichia coli. J Infect Dis (1984) 1.01
Local cytokine production in a murine model of Escherichia coli pyelonephritis. J Clin Invest (1992) 1.01
Use of a Chlamydia trachomatis DNA probe for detection of ocular chlamydiae. J Clin Microbiol (1989) 0.99
Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model. Infect Immun (1991) 0.96
Identification and characterization of a new family of high-affinity receptors for Escherichia coli heat-stable enterotoxin in rat intestinal membranes. Biochemistry (1991) 0.94
Transformation of Actinobacillus pleuropneumoniae and analysis of R factors by electroporation. Am J Vet Res (1989) 0.94
Administration in vivo of recombinant interleukin 2 protects mice against septic death. J Clin Invest (1987) 0.93
A common antigenic determinant found in two functionally unrelated toxins. J Exp Med (1984) 0.90
Epitopes of Escherichia coli alpha-hemolysin: identification of monoclonal antibodies that prevent hemolysis. Infect Immun (1990) 0.89
Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel. Cancer Treat Rev (2010) 0.89
Molecular characterization of Vibrio cholerae O139 isolates from Asia. Am J Trop Med Hyg (1995) 0.89
Intestinal receptor for heat-stable enterotoxin of Escherichia coli is tightly coupled to a novel form of particulate guanylate cyclase. Infect Immun (1986) 0.88
Enhanced cell-mediated protection against fatal Escherichia coli septicemia induced by treatment with recombinant IL-2. J Immunol (1989) 0.85
A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia. Leukemia (1997) 0.83
Uropathogenic Escherichia coli: molecular mechanisms of adherence. Adv Exp Med Biol (1987) 0.83
Influence of a glycine or proline substitution on the functional properties of a 14-amino-acid analog of Escherichia coli heat-stable enterotoxin. Infect Immun (1989) 0.82
Both naive and memory CD4 T cell subsets become anergic during MAIDS and each subset can sustain disease. J Immunol (1994) 0.82
Heterogeneity of intestinal receptors for Escherichia coli heat-stable enterotoxin. Infect Immun (1990) 0.82
CD4 T cell anergy in murine AIDS: costimulation via CD28 and the addition of IL-12 are not sufficient to rescue anergic CD4 T cells. J Immunol (1997) 0.81
Adult respiratory distress syndrome. A live E coli septic primate model. Am J Pathol (1987) 0.81
Pulmonary edema after Escherichia coli peritonitis correlates with thiobarbituric-acid-reactive materials in bronchoalveolar lavage fluid. Am Rev Respir Dis (1988) 0.81
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Ann Oncol (2017) 0.80
Affinity purification of functional receptors for Escherichia coli heat-stable enterotoxin from rat intestine. Biochemistry (1992) 0.79
Enterotoxigenic Escherichia coli diarrhea in children less than five years of age in central Java. Am J Trop Med Hyg (1996) 0.79
The effects of prostaglandin E1 on the adult respiratory distress syndrome in septic primates. Am Rev Respir Dis (1986) 0.79
ICON 2013: practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breastcancer. Indian J Cancer (2014) 0.78
Pharmacokinetics of zidovudine alone and in combination with oxazepam in the HIV infected patient. J Acquir Immune Defic Syndr (1993) 0.78
Hematopoiesis and the inosine modification in transfer RNA. Proc Soc Exp Biol Med (1985) 0.77
Solubilization and characterization of functionally coupled Escherichia coli heat-stable toxin receptors and particulate guanylate cyclase associated with the cytoskeleton compartment of intestinal membranes. Int J Biochem (1993) 0.76
Rat intestinal cell atrial natriuretic peptide receptor coupled to guanylate cyclase. Gastroenterology (1990) 0.75
Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients. Bone Marrow Transplant (2000) 0.75
Enhancement of the chemical transformation of Chinese hamster embryo cells in vitro by 7-methylguanine. Cancer Res (1987) 0.75
Synthetic peptides protect against infection in a model of experimental pyelonephritis in mice. Ann Sclavo Collana Monogr (1986) 0.75
[Ocular disorders caused by lead and carbon disulfide]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol (1976) 0.75
Topical tetracycline: potential for allergic reaction or bacterial resistance. Compend Contin Educ Dent (1997) 0.75
[Adaptability and the oculomotor system]. Fiziol Norm Patol (1973) 0.75
[Pathological physiology of acquired dyschromatopsia]. Fiziol Norm Patol (1973) 0.75
Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis. J Acquir Immune Defic Syndr (1992) 0.75
[Results of current function tests in the diagnosis of glaucoma]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol (1977) 0.75
[Post-traumatic retinal detachment in children]. Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol (1976) 0.75